Sequence is celebrating our 20th Anniversary!

Watch the Video
All Projects

Project Biogen: Equipment Commissioning for Facility Expansion


Client Overview

Biogen Inc. is a biopharmaceutical company that focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Durham facility is a 250,000-square-foot LSM plant with the capability to run up to 120,000 liters of bioreactor capacity.

Sequence Scope

Sequence was awarded the scope for renovation of an existing manufacturing facility which included: Upstream/ Downstream Processing Suites, Buffer Prep, and new process equipment. Sequence developed the commissioning master plan for the Facilities, Utilities, and Process Equipment and performed commissioning services for twelve (12) seed train bioreactors and four (4) separate purifications systems, including development and execution of all commissioning documentation for all in scope process equipment. The Sequence team included 13 team members. Sequence Project leads were responsible for planning all activities for these resources, including scheduling across two shifts. This effort resulted in successful turnover to site validation and production without delays to production schedule.

Life Impact

  • Biogen is making advancements in pharmaceutical manufacturing and medical research programs. Its active research includes treatments for conditions like multiple sclerosis, spinal muscular atrophy and other serious neurological conditions.

Get Started

How can we support your project success?

Contact Us
  • Global Headquarters
    2100 Gateway Center Blvd, Suite 301
    Morrisville, NC 27560

  • Northeast Office
    1 Speen Street, Suite 120
    Framingham, MA 01701

Sign up for our email newsletter
white sequence logo

Accelerating time to market through proven quality and compliance solutions.

© 2022 Sequence, Inc. All rights reserved.